FINWIRES · TerminalLIVE
FINWIRES

Elevance Health Avoids CMS Sanctions After Attesting to Corrective Steps

By

Price: $393.92, Change: $+1.17, Percent Change: +0.30%

Related Articles

Wire

Donaldson Raises Quarterly Dividend to $0.32 a Share, Payable June 30 to Shareholders of Record on June 15

Donaldson Raises Quarterly Dividend to $0.32 a Share, Payable June 30 to Shareholders of Record on June 15

$DCI
Wire

Cuprina Completes Reverse Split, Seeks Nasdaq Hearing to Avoid Delisting

Cuprina Holdings (CUPR) said it completed a reverse stock split on Wednesday and requested a hearing before a Nasdaq panel in response to a staff determination letter received the same day.The letter notified the company that because it failed to regain compliance with Nasdaq's $1 minimum bid price requirement, its securities will be scheduled for delisting unless it appeals the determination, Cuprina said Friday in a statement.The company filed its hearing request on Thursday.Cuprina said the share consolidation completed Wednesday is expected to bring its bid price back into compliance with the exchange requirement.Price: $2.45, Change: $-0.85, Percent Change: -25.64%

$CUPR
Wire

MannKind Says FDA Approves Afrezza for Children, Adolescents With Diabetes

MannKind (MNKD) said Friday the US Food and Drug Administration approved Afrezza, its inhaled mealtime insulin, for use in children and adolescents aged six and older with type 1 or type 2 diabetes.The approval expands Afrezza's label beyond adults and was supported by results from the phase 3 INHALE-1 study and additional long-term safety and efficacy data, the company said.MannKind said eligible patients can access Afrezza for $35 or less per month through its patient support program.Price: $3.80, Change: $+0.16, Percent Change: +4.40%

$MNKD